Sr MD General Counsel Marcus Jonathan L sold 3,291 shares ($1.1M) at $333.37 on 2026-03-17; retains 7,192 shares post-transaction.
Senior executive Marcus Jonathan L sold 3,291 shares of CME at $333.37, representing a -31.4% reduction in his CME holdings, while retaining 7,192 shares post-transaction. The transaction occurred at a price $22.66 above the current market price of $310.71, reflecting a sale at a relative premium to recent levels. CME trades at a P/E of 5.03 with $1.5B in quarterly revenue and $908.0M net income, exhibiting solid fundamental performance with 6.4% annual revenue growth. The sale's significance lies in the material reduction of executive exposure to the company, though the substantial retained stake of 7,192 shares indicates continued meaningful ownership alignment.